nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0316	0.0433	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0316	0.0433	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0273	0.0374	CbGbCtD
Temsirolimus—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0273	0.0374	CbGbCtD
Temsirolimus—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0265	0.0363	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0265	0.0363	CbGbCtD
Temsirolimus—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0262	0.0359	CbGbCtD
Temsirolimus—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.024	0.0328	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.024	0.0328	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.024	0.0328	CbGbCtD
Temsirolimus—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.024	0.0328	CbGbCtD
Temsirolimus—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0237	0.0325	CbGbCtD
Temsirolimus—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0237	0.0325	CbGbCtD
Temsirolimus—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0205	0.028	CbGbCtD
Temsirolimus—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0199	0.0272	CbGbCtD
Temsirolimus—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.018	0.0246	CbGbCtD
Temsirolimus—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.018	0.0246	CbGbCtD
Temsirolimus—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0171	0.0234	CbGbCtD
Temsirolimus—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0171	0.0234	CbGbCtD
Temsirolimus—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0161	0.022	CbGbCtD
Temsirolimus—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0161	0.022	CbGbCtD
Temsirolimus—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0154	0.0211	CbGbCtD
Temsirolimus—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0145	0.0199	CbGbCtD
Temsirolimus—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0145	0.0199	CbGbCtD
Temsirolimus—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0133	0.0182	CbGbCtD
Temsirolimus—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0129	0.0177	CbGbCtD
Temsirolimus—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0126	0.0172	CbGbCtD
Temsirolimus—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0122	0.0167	CbGbCtD
Temsirolimus—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.016	CbGbCtD
Temsirolimus—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.016	CbGbCtD
Temsirolimus—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0112	0.0154	CbGbCtD
Temsirolimus—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.011	0.0151	CbGbCtD
Temsirolimus—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0151	CbGbCtD
Temsirolimus—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0109	0.0149	CbGbCtD
Temsirolimus—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0102	0.014	CbGbCtD
Temsirolimus—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0102	0.014	CbGbCtD
Temsirolimus—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00925	0.0127	CbGbCtD
Temsirolimus—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00925	0.0127	CbGbCtD
Temsirolimus—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00867	0.0119	CbGbCtD
Temsirolimus—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00798	0.0109	CbGbCtD
Temsirolimus—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00775	0.0106	CbGbCtD
Temsirolimus—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00701	0.0096	CbGbCtD
Temsirolimus—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00701	0.0096	CbGbCtD
Temsirolimus—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00672	0.0092	CbGbCtD
Temsirolimus—MTOR—blood plasma—acquired immunodeficiency syndrome	0.00309	0.0714	CbGeAlD
Temsirolimus—FKBP1A—blood plasma—acquired immunodeficiency syndrome	0.00278	0.0642	CbGeAlD
Temsirolimus—MTOR—retina—acquired immunodeficiency syndrome	0.00169	0.0391	CbGeAlD
Temsirolimus—FKBP1A—retina—acquired immunodeficiency syndrome	0.00152	0.0352	CbGeAlD
Temsirolimus—MTOR—skin of body—acquired immunodeficiency syndrome	0.00148	0.0343	CbGeAlD
Temsirolimus—FKBP1A—skin of body—acquired immunodeficiency syndrome	0.00133	0.0309	CbGeAlD
Temsirolimus—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00121	0.028	CbGeAlD
Temsirolimus—MTOR—lymphoid tissue—acquired immunodeficiency syndrome	0.0012	0.0278	CbGeAlD
Temsirolimus—MTOR—digestive system—acquired immunodeficiency syndrome	0.00119	0.0275	CbGeAlD
Temsirolimus—MTOR—blood—acquired immunodeficiency syndrome	0.00113	0.0262	CbGeAlD
Temsirolimus—MTOR—bone marrow—acquired immunodeficiency syndrome	0.00109	0.0253	CbGeAlD
Temsirolimus—MTOR—spinal cord—acquired immunodeficiency syndrome	0.00109	0.0252	CbGeAlD
Temsirolimus—FKBP1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00108	0.025	CbGeAlD
Temsirolimus—FKBP1A—digestive system—acquired immunodeficiency syndrome	0.00107	0.0247	CbGeAlD
Temsirolimus—MTOR—vagina—acquired immunodeficiency syndrome	0.00105	0.0242	CbGeAlD
Temsirolimus—FKBP1A—blood—acquired immunodeficiency syndrome	0.00102	0.0235	CbGeAlD
Temsirolimus—MTOR—lung—acquired immunodeficiency syndrome	0.000992	0.0229	CbGeAlD
Temsirolimus—FKBP1A—bone marrow—acquired immunodeficiency syndrome	0.000984	0.0228	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—acquired immunodeficiency syndrome	0.00098	0.0227	CbGeAlD
Temsirolimus—FKBP1A—vagina—acquired immunodeficiency syndrome	0.000943	0.0218	CbGeAlD
Temsirolimus—MTOR—nervous system—acquired immunodeficiency syndrome	0.000918	0.0212	CbGeAlD
Temsirolimus—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000907	0.021	CbGeAlD
Temsirolimus—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000893	0.0207	CbGeAlD
Temsirolimus—FKBP1A—lung—acquired immunodeficiency syndrome	0.000892	0.0206	CbGeAlD
Temsirolimus—MTOR—central nervous system—acquired immunodeficiency syndrome	0.000884	0.0204	CbGeAlD
Temsirolimus—FKBP1A—nervous system—acquired immunodeficiency syndrome	0.000826	0.0191	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—acquired immunodeficiency syndrome	0.000795	0.0184	CbGeAlD
Temsirolimus—MTOR—brain—acquired immunodeficiency syndrome	0.000702	0.0162	CbGeAlD
Temsirolimus—MTOR—lymph node—acquired immunodeficiency syndrome	0.000678	0.0157	CbGeAlD
Temsirolimus—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000642	0.0149	CbGeAlD
Temsirolimus—FKBP1A—brain—acquired immunodeficiency syndrome	0.000631	0.0146	CbGeAlD
Temsirolimus—FKBP1A—lymph node—acquired immunodeficiency syndrome	0.00061	0.0141	CbGeAlD
Temsirolimus—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000465	0.0108	CbGeAlD
Temsirolimus—CYP3A5—blood—acquired immunodeficiency syndrome	0.000443	0.0102	CbGeAlD
Temsirolimus—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000411	0.0095	CbGeAlD
Temsirolimus—CYP3A5—lung—acquired immunodeficiency syndrome	0.000388	0.00898	CbGeAlD
Temsirolimus—Tacrolimus—ALB—acquired immunodeficiency syndrome	0.000356	1	CrCbGaD
Temsirolimus—ABCB1—retina—acquired immunodeficiency syndrome	0.000352	0.00814	CbGeAlD
Temsirolimus—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000349	0.00807	CbGeAlD
Temsirolimus—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000343	0.00794	CbGeAlD
Temsirolimus—CYP3A4—blood—acquired immunodeficiency syndrome	0.000332	0.00769	CbGeAlD
Temsirolimus—CYP2D6—blood—acquired immunodeficiency syndrome	0.000327	0.00757	CbGeAlD
Temsirolimus—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00027	0.00624	CbGeAlD
Temsirolimus—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000266	0.00614	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00026	0.00601	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000256	0.00591	CbGeAlD
Temsirolimus—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00025	0.00578	CbGeAlD
Temsirolimus—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000247	0.00571	CbGeAlD
Temsirolimus—ABCB1—blood—acquired immunodeficiency syndrome	0.000235	0.00544	CbGeAlD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—CCNT1—acquired immunodeficiency syndrome	0.000232	0.0615	CbGpPWpGaD
Temsirolimus—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000228	0.00527	CbGeAlD
Temsirolimus—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000227	0.00524	CbGeAlD
Temsirolimus—ABCB1—vagina—acquired immunodeficiency syndrome	0.000218	0.00505	CbGeAlD
Temsirolimus—ABCB1—lung—acquired immunodeficiency syndrome	0.000206	0.00477	CbGeAlD
Temsirolimus—CYP2D6—brain—acquired immunodeficiency syndrome	0.000203	0.0047	CbGeAlD
Temsirolimus—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000191	0.00442	CbGeAlD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.000187	0.0495	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.000185	0.049	CbGpPWpGaD
Temsirolimus—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000184	0.00425	CbGeAlD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.000182	0.0482	CbGpPWpGaD
Temsirolimus—ABCB1—brain—acquired immunodeficiency syndrome	0.000146	0.00338	CbGeAlD
Temsirolimus—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000141	0.00326	CbGeAlD
Temsirolimus—MTOR—IL12-mediated signaling events—CCL4—acquired immunodeficiency syndrome	0.000133	0.0354	CbGpPWpGaD
Temsirolimus—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000129	0.000578	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000578	CcSEcCtD
Temsirolimus—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000577	CcSEcCtD
Temsirolimus—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000577	CcSEcCtD
Temsirolimus—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000576	CcSEcCtD
Temsirolimus—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000573	CcSEcCtD
Temsirolimus—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000572	CcSEcCtD
Temsirolimus—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000572	CcSEcCtD
Temsirolimus—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.000572	CcSEcCtD
Temsirolimus—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000571	CcSEcCtD
Temsirolimus—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000571	CcSEcCtD
Temsirolimus—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000569	CcSEcCtD
Temsirolimus—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000567	CcSEcCtD
Temsirolimus—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000567	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000567	CcSEcCtD
Temsirolimus—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000566	CcSEcCtD
Temsirolimus—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.000564	CcSEcCtD
Temsirolimus—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000126	0.000564	CcSEcCtD
Temsirolimus—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000563	CcSEcCtD
Temsirolimus—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000563	CcSEcCtD
Temsirolimus—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000561	CcSEcCtD
Temsirolimus—Rash—Didanosine—acquired immunodeficiency syndrome	0.000125	0.000559	CcSEcCtD
Temsirolimus—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000559	CcSEcCtD
Temsirolimus—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000559	CcSEcCtD
Temsirolimus—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000124	0.000559	CcSEcCtD
Temsirolimus—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000556	CcSEcCtD
Temsirolimus—Headache—Didanosine—acquired immunodeficiency syndrome	0.000124	0.000556	CcSEcCtD
Temsirolimus—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000555	CcSEcCtD
Temsirolimus—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000554	CcSEcCtD
Temsirolimus—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000553	CcSEcCtD
Temsirolimus—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000123	0.000553	CcSEcCtD
Temsirolimus—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000552	CcSEcCtD
Temsirolimus—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000551	CcSEcCtD
Temsirolimus—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00055	CcSEcCtD
Temsirolimus—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000549	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000547	CcSEcCtD
Temsirolimus—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000547	CcSEcCtD
Temsirolimus—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.000546	CcSEcCtD
Temsirolimus—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000546	CcSEcCtD
Temsirolimus—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000121	0.000545	CcSEcCtD
Temsirolimus—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000544	CcSEcCtD
Temsirolimus—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000543	CcSEcCtD
Temsirolimus—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000543	CcSEcCtD
Temsirolimus—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000543	CcSEcCtD
Temsirolimus—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000541	CcSEcCtD
Temsirolimus—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000541	CcSEcCtD
Temsirolimus—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000541	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000539	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000537	CcSEcCtD
Temsirolimus—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000537	CcSEcCtD
Temsirolimus—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000537	CcSEcCtD
Temsirolimus—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000536	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000536	CcSEcCtD
Temsirolimus—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000536	CcSEcCtD
Temsirolimus—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000535	CcSEcCtD
Temsirolimus—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000532	CcSEcCtD
Temsirolimus—Pain—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000532	CcSEcCtD
Temsirolimus—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000532	CcSEcCtD
Temsirolimus—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000532	CcSEcCtD
Temsirolimus—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00053	CcSEcCtD
Temsirolimus—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000529	CcSEcCtD
Temsirolimus—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000529	CcSEcCtD
Temsirolimus—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000529	CcSEcCtD
Temsirolimus—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000527	CcSEcCtD
Temsirolimus—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000117	0.000527	CcSEcCtD
Temsirolimus—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000524	CcSEcCtD
Temsirolimus—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000524	CcSEcCtD
Temsirolimus—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000523	CcSEcCtD
Temsirolimus—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000522	CcSEcCtD
Temsirolimus—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000522	CcSEcCtD
Temsirolimus—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000522	CcSEcCtD
Temsirolimus—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000521	CcSEcCtD
Temsirolimus—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00052	CcSEcCtD
Temsirolimus—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000519	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000519	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000513	CcSEcCtD
Temsirolimus—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000511	CcSEcCtD
Temsirolimus—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000511	CcSEcCtD
Temsirolimus—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.000511	CcSEcCtD
Temsirolimus—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00051	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000509	CcSEcCtD
Temsirolimus—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000113	0.000509	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000509	CcSEcCtD
Temsirolimus—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000509	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000508	CcSEcCtD
Temsirolimus—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000507	CcSEcCtD
Temsirolimus—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000507	CcSEcCtD
Temsirolimus—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000507	CcSEcCtD
Temsirolimus—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000505	CcSEcCtD
Temsirolimus—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000503	CcSEcCtD
Temsirolimus—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000503	CcSEcCtD
Temsirolimus—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000112	0.000503	CcSEcCtD
Temsirolimus—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000112	0.000502	CcSEcCtD
Temsirolimus—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000502	CcSEcCtD
Temsirolimus—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000112	0.000502	CcSEcCtD
Temsirolimus—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000501	CcSEcCtD
Temsirolimus—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.0005	CcSEcCtD
Temsirolimus—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.0005	CcSEcCtD
Temsirolimus—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000498	CcSEcCtD
Temsirolimus—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000498	CcSEcCtD
Temsirolimus—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000498	CcSEcCtD
Temsirolimus—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000498	CcSEcCtD
Temsirolimus—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000497	CcSEcCtD
Temsirolimus—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000496	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000495	CcSEcCtD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.00011	0.0291	CbGpPWpGaD
Temsirolimus—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000492	CcSEcCtD
Temsirolimus—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000492	CcSEcCtD
Temsirolimus—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000491	CcSEcCtD
Temsirolimus—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000491	CcSEcCtD
Temsirolimus—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00049	CcSEcCtD
Temsirolimus—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000109	0.00049	CcSEcCtD
Temsirolimus—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000489	CcSEcCtD
Temsirolimus—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000487	CcSEcCtD
Temsirolimus—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000487	CcSEcCtD
Temsirolimus—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000486	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000486	CcSEcCtD
Temsirolimus—Rash—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000486	CcSEcCtD
Temsirolimus—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000485	CcSEcCtD
Temsirolimus—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000485	CcSEcCtD
Temsirolimus—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000484	CcSEcCtD
Temsirolimus—Headache—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000482	CcSEcCtD
Temsirolimus—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000482	CcSEcCtD
Temsirolimus—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000481	CcSEcCtD
Temsirolimus—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000481	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000481	CcSEcCtD
Temsirolimus—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.00048	CcSEcCtD
Temsirolimus—Rash—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000478	CcSEcCtD
Temsirolimus—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000478	CcSEcCtD
Temsirolimus—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000478	CcSEcCtD
Temsirolimus—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000478	CcSEcCtD
Temsirolimus—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000477	CcSEcCtD
Temsirolimus—Headache—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000475	CcSEcCtD
Temsirolimus—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000475	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000474	CcSEcCtD
Temsirolimus—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000474	CcSEcCtD
Temsirolimus—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000474	CcSEcCtD
Temsirolimus—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000471	CcSEcCtD
Temsirolimus—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000469	CcSEcCtD
Temsirolimus—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000468	CcSEcCtD
Temsirolimus—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000465	CcSEcCtD
Temsirolimus—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000465	CcSEcCtD
Temsirolimus—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000464	CcSEcCtD
Temsirolimus—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000464	CcSEcCtD
Temsirolimus—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000463	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00046	CcSEcCtD
Temsirolimus—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000459	CcSEcCtD
Temsirolimus—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000459	CcSEcCtD
Temsirolimus—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000458	CcSEcCtD
Temsirolimus—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000457	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000456	CcSEcCtD
Temsirolimus—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000455	CcSEcCtD
Temsirolimus—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000453	CcSEcCtD
Temsirolimus—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000452	CcSEcCtD
Temsirolimus—Nausea—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000451	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000449	CcSEcCtD
Temsirolimus—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.000449	CcSEcCtD
Temsirolimus—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.95e-05	0.000447	CcSEcCtD
Temsirolimus—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.000447	CcSEcCtD
Temsirolimus—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000445	CcSEcCtD
Temsirolimus—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000445	CcSEcCtD
Temsirolimus—Pain—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000445	CcSEcCtD
Temsirolimus—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.000445	CcSEcCtD
Temsirolimus—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.000445	CcSEcCtD
Temsirolimus—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.86e-05	0.000443	CcSEcCtD
Temsirolimus—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.00044	CcSEcCtD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	9.76e-05	0.0259	CbGpPWpGaD
Temsirolimus—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.7e-05	0.000435	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.7e-05	0.000435	CcSEcCtD
Temsirolimus—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.65e-05	0.000433	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.63e-05	0.000432	CcSEcCtD
Temsirolimus—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.000432	CcSEcCtD
Temsirolimus—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000432	CcSEcCtD
Temsirolimus—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000428	CcSEcCtD
Temsirolimus—Pain—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000428	CcSEcCtD
Temsirolimus—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000426	CcSEcCtD
Temsirolimus—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.49e-05	0.000426	CcSEcCtD
Temsirolimus—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.48e-05	0.000426	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000426	CcSEcCtD
Temsirolimus—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000425	CcSEcCtD
Temsirolimus—Rash—Zidovudine—acquired immunodeficiency syndrome	9.4e-05	0.000422	CcSEcCtD
Temsirolimus—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.4e-05	0.000422	CcSEcCtD
Temsirolimus—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.39e-05	0.000422	CcSEcCtD
Temsirolimus—Headache—Zidovudine—acquired immunodeficiency syndrome	9.34e-05	0.000419	CcSEcCtD
Temsirolimus—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000416	CcSEcCtD
Temsirolimus—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.25e-05	0.000415	CcSEcCtD
Temsirolimus—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.23e-05	0.000415	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.19e-05	0.000413	CcSEcCtD
Temsirolimus—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000412	CcSEcCtD
Temsirolimus—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.17e-05	0.000412	CcSEcCtD
Temsirolimus—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000411	CcSEcCtD
Temsirolimus—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000411	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.12e-05	0.00041	CcSEcCtD
Temsirolimus—MTOR—IL12-mediated signaling events—CCL3—acquired immunodeficiency syndrome	9.11e-05	0.0242	CbGpPWpGaD
Temsirolimus—Pain—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000409	CcSEcCtD
Temsirolimus—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000409	CcSEcCtD
Temsirolimus—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.000404	CcSEcCtD
Temsirolimus—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.000402	CcSEcCtD
Temsirolimus—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000398	CcSEcCtD
Temsirolimus—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.85e-05	0.000398	CcSEcCtD
Temsirolimus—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.000396	CcSEcCtD
Temsirolimus—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.000396	CcSEcCtD
Temsirolimus—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.81e-05	0.000396	CcSEcCtD
Temsirolimus—Rash—Indinavir—acquired immunodeficiency syndrome	8.74e-05	0.000392	CcSEcCtD
Temsirolimus—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.73e-05	0.000392	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.000391	CcSEcCtD
Temsirolimus—Headache—Indinavir—acquired immunodeficiency syndrome	8.69e-05	0.00039	CcSEcCtD
Temsirolimus—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.66e-05	0.000389	CcSEcCtD
Temsirolimus—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.58e-05	0.000385	CcSEcCtD
Temsirolimus—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.54e-05	0.000383	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	8.53e-05	0.0226	CbGpPWpGaD
Temsirolimus—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000378	CcSEcCtD
Temsirolimus—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000378	CcSEcCtD
Temsirolimus—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.33e-05	0.000374	CcSEcCtD
Temsirolimus—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.32e-05	0.000373	CcSEcCtD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	8.29e-05	0.022	CbGpPWpGaD
Temsirolimus—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.29e-05	0.000372	CcSEcCtD
Temsirolimus—Rash—Efavirenz—acquired immunodeficiency syndrome	8.26e-05	0.000371	CcSEcCtD
Temsirolimus—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.25e-05	0.00037	CcSEcCtD
Temsirolimus—Nausea—Indinavir—acquired immunodeficiency syndrome	8.23e-05	0.00037	CcSEcCtD
Temsirolimus—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.22e-05	0.000369	CcSEcCtD
Temsirolimus—Headache—Efavirenz—acquired immunodeficiency syndrome	8.21e-05	0.000368	CcSEcCtD
Temsirolimus—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000368	CcSEcCtD
Temsirolimus—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000359	CcSEcCtD
Temsirolimus—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.97e-05	0.000358	CcSEcCtD
Temsirolimus—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000356	CcSEcCtD
Temsirolimus—Rash—Delavirdine—acquired immunodeficiency syndrome	7.9e-05	0.000355	CcSEcCtD
Temsirolimus—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.89e-05	0.000354	CcSEcCtD
Temsirolimus—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000354	CcSEcCtD
Temsirolimus—Headache—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.000353	CcSEcCtD
Temsirolimus—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.84e-05	0.000352	CcSEcCtD
Temsirolimus—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.78e-05	0.000349	CcSEcCtD
Temsirolimus—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000344	CcSEcCtD
Temsirolimus—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.64e-05	0.000343	CcSEcCtD
Temsirolimus—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000343	CcSEcCtD
Temsirolimus—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000338	CcSEcCtD
Temsirolimus—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.44e-05	0.000334	CcSEcCtD
Temsirolimus—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.38e-05	0.000331	CcSEcCtD
Temsirolimus—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.37e-05	0.000331	CcSEcCtD
Temsirolimus—Rash—Ritonavir—acquired immunodeficiency syndrome	7.31e-05	0.000328	CcSEcCtD
Temsirolimus—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.3e-05	0.000328	CcSEcCtD
Temsirolimus—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000327	CcSEcCtD
Temsirolimus—Headache—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000326	CcSEcCtD
Temsirolimus—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000318	CcSEcCtD
Temsirolimus—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.04e-05	0.000316	CcSEcCtD
Temsirolimus—Rash—Saquinavir—acquired immunodeficiency syndrome	7.03e-05	0.000316	CcSEcCtD
Temsirolimus—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.03e-05	0.000316	CcSEcCtD
Temsirolimus—Headache—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.000314	CcSEcCtD
Temsirolimus—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.88e-05	0.000309	CcSEcCtD
Temsirolimus—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.77e-05	0.000304	CcSEcCtD
Temsirolimus—Rash—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000301	CcSEcCtD
Temsirolimus—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.7e-05	0.000301	CcSEcCtD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	6.68e-05	0.0177	CbGpPWpGaD
Temsirolimus—Headache—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000299	CcSEcCtD
Temsirolimus—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.63e-05	0.000297	CcSEcCtD
Temsirolimus—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.32e-05	0.000284	CcSEcCtD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	5.92e-05	0.0157	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	5.92e-05	0.0157	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	5.91e-05	0.0157	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	5.82e-05	0.0154	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD8A—acquired immunodeficiency syndrome	5.81e-05	0.0154	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	5.72e-05	0.0152	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	5.72e-05	0.0152	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL4—acquired immunodeficiency syndrome	5.71e-05	0.0152	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	5.56e-05	0.0148	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CCR5—acquired immunodeficiency syndrome	5.31e-05	0.0141	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	4.99e-05	0.0132	CbGpPWpGaD
Temsirolimus—MTOR—IL2 signaling events mediated by PI3K—IL2—acquired immunodeficiency syndrome	4.52e-05	0.012	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IFNG—acquired immunodeficiency syndrome	4.51e-05	0.012	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	4.32e-05	0.0115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	3.68e-05	0.00977	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	3.57e-05	0.00948	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IFNG—acquired immunodeficiency syndrome	3.45e-05	0.00916	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	3.33e-05	0.00885	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	3.18e-05	0.00842	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	3.12e-05	0.00829	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.09e-05	0.0082	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.09e-05	0.0082	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	3.07e-05	0.00814	CbGpPWpGaD
Temsirolimus—MTOR—Costimulation by the CD28 family—CD4—acquired immunodeficiency syndrome	3.02e-05	0.008	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CD79A—acquired immunodeficiency syndrome	2.8e-05	0.00744	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	2.78e-05	0.00736	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APOBEC3G—acquired immunodeficiency syndrome	2.71e-05	0.00719	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	2.68e-05	0.0071	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.67e-05	0.00707	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	2.55e-05	0.00676	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	2.4e-05	0.00636	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	2.35e-05	0.00623	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2.31e-05	0.00614	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCNT1—acquired immunodeficiency syndrome	2.31e-05	0.00612	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	2.21e-05	0.00585	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	2.19e-05	0.00582	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	2.09e-05	0.00555	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.03e-05	0.00538	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.03e-05	0.00538	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	1.97e-05	0.00523	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	1.93e-05	0.00512	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	1.87e-05	0.00495	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MBL2—acquired immunodeficiency syndrome	1.72e-05	0.00456	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	1.71e-05	0.00453	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.61e-05	0.00428	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.61e-05	0.00428	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.57e-05	0.00417	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.53e-05	0.00405	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	1.5e-05	0.00398	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.46e-05	0.00387	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	1.36e-05	0.00362	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CCR2—acquired immunodeficiency syndrome	1.35e-05	0.00357	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—acquired immunodeficiency syndrome	1.33e-05	0.00352	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	1.32e-05	0.00349	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCNT1—acquired immunodeficiency syndrome	1.3e-05	0.00344	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	1.28e-05	0.0034	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	1.28e-05	0.0034	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	1.26e-05	0.00335	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ACTG1—acquired immunodeficiency syndrome	1.22e-05	0.00323	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	1.21e-05	0.00322	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CXCR4—acquired immunodeficiency syndrome	1.21e-05	0.00321	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.19e-05	0.00316	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	1.15e-05	0.00306	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	1.14e-05	0.00301	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	1.13e-05	0.003	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	1.07e-05	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	1.07e-05	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	1.06e-05	0.00282	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.06e-05	0.00281	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MBL2—acquired immunodeficiency syndrome	1e-05	0.00266	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.98e-06	0.00265	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	9.22e-06	0.00245	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	9.13e-06	0.00242	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	9.12e-06	0.00242	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	9.11e-06	0.00242	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	9.1e-06	0.00241	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.08e-06	0.00241	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.08e-06	0.00241	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.02e-06	0.00239	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	8.77e-06	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	8.71e-06	0.00231	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	8.57e-06	0.00227	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.48e-06	0.00225	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.48e-06	0.00225	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—acquired immunodeficiency syndrome	8.3e-06	0.0022	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.21e-06	0.00218	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	8.19e-06	0.00217	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	8.15e-06	0.00216	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	8.11e-06	0.00215	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—acquired immunodeficiency syndrome	8.07e-06	0.00214	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CCR2—acquired immunodeficiency syndrome	7.85e-06	0.00208	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.75e-06	0.00206	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	7.72e-06	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—acquired immunodeficiency syndrome	7.59e-06	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	7.59e-06	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	7.59e-06	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	7.52e-06	0.002	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	7.45e-06	0.00198	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	7.42e-06	0.00197	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNA1—acquired immunodeficiency syndrome	7.07e-06	0.00187	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	6.88e-06	0.00182	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—acquired immunodeficiency syndrome	6.86e-06	0.00182	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CXCR4—acquired immunodeficiency syndrome	6.81e-06	0.00181	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	6.72e-06	0.00178	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	6.48e-06	0.00172	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.45e-06	0.00171	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.36e-06	0.00169	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.85e-06	0.00155	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.81e-06	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.61e-06	0.00149	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—acquired immunodeficiency syndrome	5.59e-06	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CSF2—acquired immunodeficiency syndrome	5.53e-06	0.00147	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—acquired immunodeficiency syndrome	5.53e-06	0.00147	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	5.51e-06	0.00146	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	5.51e-06	0.00146	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—acquired immunodeficiency syndrome	5.45e-06	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-B—acquired immunodeficiency syndrome	5.32e-06	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	5.24e-06	0.00139	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—acquired immunodeficiency syndrome	5.21e-06	0.00138	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—acquired immunodeficiency syndrome	5.17e-06	0.00137	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.07e-06	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.77e-06	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.77e-06	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—acquired immunodeficiency syndrome	4.67e-06	0.00124	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	4.24e-06	0.00112	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	3.81e-06	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.63e-06	0.000963	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	3.6e-06	0.000956	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.57e-06	0.000948	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.36e-06	0.000891	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—acquired immunodeficiency syndrome	3.29e-06	0.000872	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.27e-06	0.000867	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—acquired immunodeficiency syndrome	3.18e-06	0.000842	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.95e-06	0.000782	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—acquired immunodeficiency syndrome	2.93e-06	0.000778	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—acquired immunodeficiency syndrome	2.92e-06	0.000775	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—acquired immunodeficiency syndrome	2.82e-06	0.000748	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.56e-06	0.000679	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.2e-06	0.000583	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.97e-06	0.000524	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.89e-06	0.000501	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—acquired immunodeficiency syndrome	1.72e-06	0.000456	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	1.59e-06	0.000422	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—acquired immunodeficiency syndrome	1.59e-06	0.000421	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.2e-06	0.000318	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-06	0.0003	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.11e-06	0.000295	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	7.39e-07	0.000196	CbGpPWpGaD
